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Abstract
Aims/hypothesis Low birthweight (BW) is associated with
increased risk of type 2 diabetes. We compared glucose metab-
olism in adult BW-discordant monozygotic (MZ) twins, there-
by controlling for genetic factors and rearing environment.
Methods Among 77,885 twins in the Danish Twin Registry,
155 of the most BW-discordant MZ twin pairs (median BW
difference 0.5 kg) were assessed using a 2 h oral glucose
tolerance test with sampling of plasma (p-)glucose, insulin,
C-peptide, glucose-dependent insulinotropic polypeptide and
glucagon-like peptide-1. HOMA for beta cell function
(HOMA-β) and insulin resistance (HOMA-IR), and also in-
sulin sensitivity index (BIGTT-SI) and acute insulin response
(BIGTT-AIR), were calculated. Subgroup analyses were per-
formed in those with: (1) double verification of BW differ-
ence; (2) difference in BW>0.5 kg; and (3) no overt metabolic
disease (type 2 diabetes, hyperlipidaemia or thyroid disease).
Results No intra-pair differences in p-glucose, insulin,
C-peptide, incretin hormones, HOMA-β, HOMA-IR or
BIGTT-SI were identified. p-Glucose at 120 min was higher
in the twins with the highest BW without metabolic disease,
and BIGTT-AIR was higher in those with the highest BW
although not in pairs with a BW difference of >0.5 kg.
Conclusions/interpretation BW-discordant MZ twins provide
no evidence for a detrimental effect of low BW on glucose
metabolism in adulthood once genetic factors and rearing
environment are controlled for.
Keywords Birthweight . Fetal programming . Incretin
hormones . Oral glucose tolerance test . Twins . Type 2
diabetes
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Introduction
Increased levels of fasting glucose and diabetes are associ-
ated with increased morbidity and premature death [1]. In
individuals with type 2 diabetes, insulin secretion is insuf-
ficient to compensate for the degree of insulin resistance [2].
Studies in twins have shown that type 2 diabetes is in part
heritable [3], but factors in early life may also predispose to
the development of type 2 diabetes. According to the fetal
origin hypothesis, intrauterine malnutrition may predispose
to adverse health outcomes in later life, including type 2
diabetes [4], and low birthweight (BW) has been associated
with an increased risk of type 2 diabetes suggesting that the
susceptibility to the development of type 2 diabetes is estab-
lished in prenatal life [5]. Support for this hypothesis has
been provided by several studies. In rats, maternal undernu-
trition changed the gene expression profile that predisposes
to altered fat deposition [6], whereas signs of increased
oxidative stress and fibrosis were discovered in pancreatic
islets in offspring of protein-restricted pregnant rats [7].
However, whether the association between early life factors
and the development of type 2 diabetes is due to fetal
programming or underlining common genetic and environ-
mental influence remains debatable. Twin status was asso-
ciated with reduced insulin sensitivity and higher incidence
rate of type 2 diabetes in a study that comprised 298 twins
and 71 singletons, indicating that pre- or postnatal program-
ming influences the development of type 2 diabetes [8].
Since the average BW of a twin is about 1 kg less than that
of a singleton [9], a higher prevalence of diabetes would be
expected in twins compared with singletons based on the
fetal origin hypothesis. Nevertheless, the prevalence of type
2 diabetes was similar in Swedish twins compared with the
general population [10], and type 2 diabetes was equally
common in 77,855 monozygotic (MZ) and dizygotic (DZ)
twins as in a random sample of 220,000 age- and sex-matched
individuals in Denmark [3].
We investigated the association between BW and indices
of glucose metabolism. Since such associations are poten-
tially explained by a number of factors, including fetal
programming, genetics and confounding from shared envi-
ronment, we recruited adult, monozygotic, extremely BW-
discordant twins. If BW is associated with health in later life
independently of genes and rearing environment, significant
differences in markers of glucose metabolism would be
expected in these individuals.
Methods
Study population The Danish Twin Registry comprised
77,855 twins, including 17,331 MZ twins, in 2010 [11].
Based on information on zygosity and BW, the 379 most
BW-discordant MZ twin pairs were identified. We aimed to
include 150 MZ twin pairs. A total of 336 MZ twin pairs
were consecutively invited by mail to participate until at
least 150 twin pairs were enrolled.
Zygosity Zygosity of the twins in the Danish Twin Registry
had previously been assigned on the basis of physical re-
semblance, which provided >95% accuracy of classification
[12], but zygosity of those included in the study was
confirmed using 12 highly polymorphic microsatellite
markers. Identity in all markers indicated >0.99 probability
of monozygosity.
Birthweight Information on BW of the twins in the Danish
Registry was retrieved from the Danish Birth Record
Registry on those born after 1973 (registered 1973–1978
and from 1979 in groups of 250 and 100 g, respectively) and
from midwife records on those born before 1973 (reported
with varying precision).
Questionnaire Participants filled out a questionnaire on
lifestyle factors, pregnancy, medication and comorbidity,
including endocrine and metabolic diseases (e.g. type 2
diabetes, hyperlipidaemia and thyroid dysfunction). In
addition, participants answered a question about who of
the twins was the heavier at birth.
Non-participation Potential participants were excluded if
they met one of the exclusion criteria. These included
inability to attend clinical evaluation and tests, present or
recent (<6 months) pregnancy, and diseases contraindicating
an overnight fast (e.g. type 1 diabetes).
Among those invited to participate in the study, 178 twin
pairs declined participation due to both twins being too ill to
participate (n04), one twin being too ill (n016), one or both
twins not being willing to participate (n074 and 25, respec-
tively), no response from one or both of the twins (n08), or
other reasons including low mobility, travel distance etc.
(n051) (Fig. 1).
Furthermore one of the twin pairs was found to be
dizygotic, based on genetic testing, and another twin pair
disagreed on who had been the heavier at birth; both of these
pairs were therefore excluded from further analyses. A third
twin pair was excluded when one of the twins became
pregnant.
In 22 cases, only one twin had filled out the question-
naire. Subgroup analyses were performed for the double
verification group of 133 pairs where both twins filled out
the questionnaire and independently agreed on who had
been the heavier at birth.
Outcomes The primary outcomes of the study were differ-
ences in fasting and glucose levels after an OGTT. Measures
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of insulin sensitivity and beta cell function, as well as
incretin hormones, were considered secondary, exploratory
variables.
Further explorations of these outcomes were conducted
in three subgroup analyses. The first subgroup analysis was
performed in those with difference in BW exceeding 0.5 kg,
to investigate whether differences in glucose metabolism
were present only in cases of extreme BW discordancy.
Since dissimilarity in BW within twin pairs may originate
from causes that are specific to twins (i.e. twin-to-twin
transfusion syndrome), analyses were repeated in twin pairs
with a smaller BW discordance (<0.5 kg). Due to the po-
tential risk of incorrect registration of BW in the public
register or birth records, the second subgroup analysis com-
prised twins who provided self-reported knowledge on BW
discordance that verified the information retrieved from the
public records. Therefore, this group comprised twins with
double verification of BW discordance. The third subgroup
analysis was performed in twins without self-reported
metabolic diseases in order to reduce effects of these
diseases and their treatment on the outcomes of interest.
The study was approved by the Local Ethics Committee
(S-20090033) and conducted in accordance with the
Helsinki II declaration. Participants consented in writing to
participate in the study.
Biochemical tests Samples were collected between 07:00
and 09:00 hours after an overnight fast of at least 8 h. A
2 h OGTT was performed using 75 g glucose dissolved in
200 ml water. Blood for glucose, insulin, C-peptide, total
glucose-dependent insulinotropic polypeptide (GIP) and
glucose-dependent insulinotropic polypeptide (GLP-1) de-
termination was collected at times 0, 30 and 120 min and
stored at −80°C until analyses. Plasma (p-)glucose, serum
(s-)insulin and s-C-peptide were measured using the glucose
oxidase technique and a time-resolved immunofluorometric
assay (AutoDELFIA; Wallac, Turku, Finland), respectively.
Total GLP-1 was determined using a radioimmunoassay
(antiserum no. 89390) specific for the C-terminal of the
GLP-1 molecule as previously described [13]. Total GIP
was measured using a C-terminally directed antiserum [13].
Body composition BMI (kg/m2) was calculated as body
weight divided by body height2.
Statistics Data are reported as mean (SD). The natural log-
arithm was used to transform skewed data. Results are
reported without adjustment for multiple testing.
HOMAs of beta cell function and insulin resistance
(HOMA-β and HOMA-IR, respectively) were calculated
using models presented by Mathews et al [14]. The insulin
sensitivity index (BIGTT-SI 0-30-120) and acute insulin
response (BIGTT-AIR0-30-120) were estimated on the basis
of the OGTT using algorithms suggested by Hansen and
colleagues [15]. The AUCs for glucose, GIP and GLP-1
were calculated using the trapezoidal method.
Two sets of analyses of the BW–glucose metabolism
association were performed. First, twins were treated as
individuals to test whether the usually observed association
between BW and glucose metabolism was present in the
sample. Second, intra-pair differences in glucose metabo-
lism were assessed.
The associations between markers of glucose metabolism
and BW were assessed using regression analysis, and sim-
ilar associations were investigated using regression analyses
that included age, BMI, sex and metabolic comorbidity
(thyroid disease, diabetes and hyperlipidaemia). Stata’s clus-
ter option was used to account for possible within-pair
correlations that might otherwise underestimate the SE in
both analyses.
In the second set of analyses, within MZ twin-pair differ-
ences (twin with higher BW vs twin with lower BW) of
continuous measures were compared using Student’s t test.
The χ2 test was used for categorical measures. Three
Danish Twin Registry: n=77,885
MZ twins: n=17,331
336 MZ pairs consecutively invited
Included: 158 twin pairs Excluded:
One pair became pregnant after inclusion
One pair due to zygosity (DZ) 
One disagreed on direction of birthweight 
difference
Causes of non-participation of the invited twins 
(in pairs):
4 : both twins too ill to participate
16: one twin too ill to participate
74: one twin not willing to participate
25: both twins not willing to participate
8: no response from one or both of the twins 
51: other causes (incl. low mobility, recent 
pregnancy or pregnancy, travel distance too far) 
Final study population: 155
379 most birthweight discordant 
MZ twin pairs selected
Fig. 1 Flowchart of the
inclusion of study participants
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subgroup analyses were performed for twin pairs character-
ised by: (1) difference in BW >0.5 kg; (2) double verifica-
tion of BW and (3) absence of any known metabolic
comorbidity. Fixed-effect regression was used to assess the
association between measures of glucose metabolism and
BW within twin pairs, with or without adjustment for BMI.
Within-pair differences of indices of glucose metabolism are
presented as scatter plots and regression lines with 95% CIs.
Calculations were performed using Stata (Stata Corp,
College Station, TX, USA).
Results
The distribution of BWs is presented in Fig. 2. Median age
and mean difference in BW were 58 years and 0.5 kg,
respectively (Table 1). Thirty-nine participants (13%)
reported thyroid disease, hyperlipidaemia or type 2 diabetes,
and 22 (56%) of these participants were from the lowest BW
group (p>0.1).
Those with the higher BW were on average heavier (3 kg,
p<0.01) and taller (1.8 cm, p<0.01), while BMI was similar
in the two groups. Subgroup analyses provided similar
results, although BMI was higher in those with the
higher BW who also reported no metabolic comorbidity
(0.7 kg/m2, p<0.01).
Results from the OGTT were available in 148 (95%)
pairs of the study population. Information on OGTT was
available in 129 (97%) of the 133 twin pairs with double
verification of BW, 118 of those 123 pairs (96%) without
overt metabolic disease and 44 of those 46 (96%) with a
>0.5 kg BW difference.
Mean p-glucose0min and p-glucose120min were 5.7 mmol/l
and 6.5 mmol/l, respectively. Median (interquartile) s-insulin0min
and s-insulin120min were 32 (22–45) and 154 (92–244) pmol/l,
respectively, and mean (SD) s-C-peptide0min and s-C-
peptide120min were 628 (358) and 2289 (1062) nmol/l, mean
(SD) GIP0min and GIP120min were 5.2 (8.1) and 28.9 (18.7)
pmol/l, and mean (SD) GLP-10min and GLP-1120min were 6.4
(3.2) and 12.0 (5.9) pmol/l, respectively. In the complete study
population, HOMA-β was 49.0%, HOMA-IR 1.3, BIGTT-
AIR 639.1 and BIGTT-SI 9.3.
Eight individuals had p-glucose120min levels exceeding
≥11.1 mmol/l (i.e. type 2 diabetes), and four of these
belonged to those with the highest BW (p>0.1). Forty-one
participants had impaired glucose tolerance (p-glucose 7.8-
11.1 mmol/l), and 24 (59%) of these were the twin with
higher BW (p>0.1). Furthermore, 247 participants had
normal glucose tolerance (<7.8 mmol/l), and 120 (49%) of
these were heaviest at birth (p>0.1).
BW was inversely associated with p-glucose120min in
bivariate (r −0.75, p<0.01) and multivariate regression
models (r −0.71, p<0.01). BW was inversely associated
with p-glucose30min and AUCglucose and directly associated
with BIGTT-SI and BIGTT-AIR in multiple regression
models. Neither GIP nor GLP1 (fasting as well as AUC)
nor any of the HOMA indices were inversely associated
with BW (Table 2).
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Table 1 Anthropometrics of the study population
Characteristic Women (n0140) Men (n0156)
Age (years) 58 (30–74) 58 (30–75)
BW (kg) 2.5 (2.1–2.8) 2.7 (2.3–3.1)
Length at birth (cm) 48 (46–50) 49 (47–51)
Within-twin-pair BW
difference (kg), median (range)
0.5 (0.2–1.3) 0.5 (0.2–1.3)
Height (cm) 165±6 178±7
Weight (kg) 63±10.8 83±13.7
BMI (kg/m2) 23.2±4.1 26.3±4.0
Data are presented as median (range) or mean±SD
Table 2 Association between BW and measures of glucose metabo-
lism using multiple regression analyses
Measure BW Model A p BW Model B p
Glucose0 –0.04 >0.1 –0.11 >0.1
Glucose30 –0.37 0.10 −0.55 0.02
Glucose120 −0.75 <0.01 −0.71 <0.01
AUC glucose −57.2 0.05 −67.5 <0.01
AUC GIP −10.3 >0.1 54.8 >0.1
AUC GLP1 −121.4 >0.1 22.1 >0.1
HOMA-IR −3.5 0.05 −3.1 0.08
HOMA-β −7.7 0.05 −5.7 >0.1
BIGTT-SIa 0.86 0.08 1.4 <0.01
BIGTT-AIRa 58.7 0.04 60.6 0.03
Results are shown as regression coefficients (r)
a Not adjusted for BMI since BMI is included in the algorithm
Model A, adjusted for cluster effect; Model B, adjusted for age, sex,
BMI, prevalent metabolic comorbidity and cluster effect
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The comparison of p-glucose in twins with the higher and
lower intra-pair BW is presented in Table 3. The within-pair
differences in p-glucose0min and p-glucose120min were not
statistically significant, but p-glucose120min was higher
in those with the higher BW in the subgroup analysis
that included individuals without any overt metabolic
comorbidity.
Neither fasting nor post-OGTT p-glucose levels differed
significantly between twin pairs with less than 0.5 kg dif-
ference in BW. p-Glucose0min and p-glucose120min differed
(twin with higher BW vs twin with lower BW) by 0.1 mmol/l
and 0.7 mmol/l (both p>0.1), respectively.
Both before and by the end of the OGTT, s-insulin and
s-C-peptide were similar in those with higher compared with
lower BW. Neither pre- nor post-OGTT GIP differed
between the BW-discordant twins. Baseline but not post-
OGTT GLP1 was higher in those with the lower BW and
double verification of BW difference; however, no differ-
ence was found after stratification according to a difference
in BW of at least 0.5 kg (Table 3).
HOMA-β as well as HOMA-IR and BIGTT-SI were
similar in those with high and low BW. BIGTT-AIR
was higher in the twin with the higher BW in the
complete study population as well as in those without
overt metabolic disease. However, BIGTT-AIR was not
statistically different in those with the largest difference
in BW (Table 4). AUC was calculated for p-glucose,
GIP and GLP-1. None of these measures differed
between those with the higher and the lower BW of
the twin pair (Table 4).
Within-pair differences in indices of glucose metabolism
are presented graphically (see electronic supplementary
material [ESM] Fig. 1). None of the slopes, except that for
BIGTT-AIR, were different from zero.
Intra-pair differences in BW were not associated with
fasting or post-OGTT p-glucose levels in fixed-effect
regression analyses, and inclusion of BMI in the models
did not change the results (ESM Table 1).
Discussion
The main findings of this study were similar levels of p-
glucose before and after a 2 h glucose tolerance test in a
large sample of MZ twins characterised by extreme BW
discordance. Subgroup analyses performed in those with
the largest difference in BW, double verification of BW,
and absence of overt metabolic disease did not suggest any
Table 3 Comparison of glucose, insulin, C-peptide and incretin hormones in BW-discordant MZ twins during a 2 h OGTT
Measure MZ pairs with complete data
on OGTT (n0148 pairs)
MZ pairs with BW difference
of >0.5 kg (n044 )
Pairs with double verification
of BW discordance (n0129)
Pairs without overt metabolic
disease (n0118)
Difference,
mean±SD or median
(interquartile range)
p Difference,
mean±SD or median
(interquartile range)
p Difference, mean±SD
or median
(interquartile range)
p Difference, mean±SD
or median
(interquartile range)
p
Height (m) 1.75±2.6 <0.01 1.85±2.4 <0.01 1.85±2.4 <0.01 1.81±2.6 <0.01
Weight (kg) 2.9±10.1 <0.01 2.9±10.3 <0.01 2.9±10.3 <0.01 3.6±9.8 <0.01
BMI (kg/m2) 0.4±3.4 >0.1 0.4±3.5 >0.1 0.4±3.5 >0.1 0.7±3.2 0.03
Glucose0 (mmol/l) 0.04±0.57 >0.1 −0.03±0.45 >0.1 0.03±0.59 >0.1 0 .06±0.57 >0.1
Glucose30 (mmol/l) −0.07±1.72 >0.1 −0.31±1.50 >0.1 0.00±1.76 >0.1 −0.07±1.71 >0.1
Glucose120 (mmol/l) 0.23±2.02 >0.1 −0.04±2.31 >0.1 0.26±2.09 >0.1 0.43±2.0 0.02
Insulin0 (pmol/l) 0 (−12, 14) >0.1
a −1 (−9, 12) >0.1a 0 (−9, 13) >0.1a 0 (−9, 13) >0.1a
Insulin30 (pmol/l) −11 (−130, 61) >0.1
a 27 (−78, 138) >0.1a −3 (−130, 61) >0.1a 0 (−124, 67) >0.1a
Insulin120 (pmol/l) 15 (−77, 76) >0.1
a 21 (−50, 71) >0.1a 15 (−67, 76) >0.1a 19 (−54, 77) >0.1a
C-peptide0 (nmol/l) 29.1±364.6 >0.1 −5.9±322.3 >0.1 31.0±384.3 >0.1 39.7±271.8 >0.1
C-peptide30 (nmol/l) −69.8±841.2 >0.1 72.8±615.1 >0.1 −51.5±835.8 >0.1 −14.3±785.2 >0.1
C-peptide120 (nmol/l) 83±1036 >0.1 124±1010 >0.1 79±1065 >0.1 128±1021 >0.1
GIP0 (pmol/l) 0.06±12.5 >0.1 0.4±17.0 >0.1 0.7±12.6 >0.1 0.1±9.7 >0.1
GIP30 (pmol/l) −0.04±18.3 >0.1 −0.1±18.2 >0.1 −0.4±18.8 >0.1 0.7±16.4 >0.1
GIP120 (pmol/l) −0.31±21.3 >0.1 −1.9±23.4 >0.1 −0.7±21.8 >0.1 −0.7±19.5 >0.1
GLP10 (pmol/l) −0.50±3.14 0.06 −0.5±3.1 >0.1 −0.6±3.2 0.04 −0.5±2.9 0.07
GLP130 (pmol/l) 0.63±11.3 >0.1 1.6±8.1 >0.1 1.0±11.1 >0.1 0.9±10.1 >0.1
GLP1120 (pmol/l) −0.57±6.64 >0.1 −0.5±6.7 >0.1 0.8±6.9 >0.1 −0.7±6.8 >0.1
Individuals with highest BW were compared with those with lowest BW using Student’s t test
a Statistical test after log-transformation
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impact of BW on glucose metabolism in later life. BW and
p-glucose levels after OGTT were inversely associated in
the twin population in the present study; however, the
absence of differences within the pairs in glucose metabo-
lism in BW-discordant MZ twins is in contrast to the fetal
origin hypothesis. Rather, our results support the notion
that the association between BW and glucose metabolism
in later life is due to genetic and rearing/environmental
confounding.
In contrast to the fetal origin hypothesis, the subgroup
analysis that included participants without overt metabolic
disease showed that glucose levels were higher in the twin
with the higher BW after the glucose-stress test. However,
the overall proportion of individuals with inappropriate
levels of glucose after the OGTTwas similar in both groups
suggesting that the observation is a chance finding rather
than an indication of a detrimental effect of high BW on
glucose metabolism in adulthood. Furthermore, the acute
insulin response appeared to be higher in those with the
higher BW. Since impaired insulin secretion has been shown
to predict development of type 2 diabetes [16], this could
indicate that low BW impairs one of the key elements of the
pathogenesis of type 2 diabetes. However, no support for
any impact of BW on beta cell function, or indeed basal
hepatic glucose production, was provided by the HOMA-β,
and the higher acute insulin response was not present in
those twins born with the largest difference in BW. While
the OGTT is useful for the detection of individuals with type
2 diabetes or impaired glucose tolerance, the ability of a 2 h
OGTT to predict the development of type 2 diabetes is
limited [17]. Taken together, the results based on fasting
glucose and OGTT neither support beneficial nor detrimen-
tal impacts of BW on current glucose levels or acute insulin
responses in adulthood.
Both GIP and GLP-1 are important, since these hormones
explain an extensive part of the postprandial amplification
of insulin secretion (i.e. the incretin effect [18]). Impairment
of the incretin effect is an early and specific sign of inade-
quate glucose metabolism [19] and, hypothetically, levels of
these hormones could be lower in individuals predisposed to
type 2 diabetes due to low BW. Although the level of fasting
GLP-1 was higher in the twin with the lower BW, levels of
GIP and GLP-1 were similar in those with higher and lower
BW during and after a 2 h OGTT, suggesting that BW is not
associated with the levels of incretin hormones measured in
later life.
Barker hypothesised that the association between BW–a
proxy for intrauterine conditions–is explained by adaptation
of bodily functions conferred by environmental changes at
crucial stages of fetal growth [4]. Several studies support the
notion. Poulsen and colleagues [20, 21] reported lower BW
in twins with abnormal glucose tolerance than in twins with
normal glucose tolerance. The same investigators also com-
pared levels of p-glucose and insulin in MZ and DZ twins
during an OGTT and reported substantially larger differ-
ences than expected on the basis of the genetic dissimilarity,
suggesting that the unfavourable intrauterine conditions in
MZ pregnancies influence glucose metabolism in later life.
Using euglycaemic–hyperinsulinaemic clamps, further sub-
stantiation was provided by demonstration of lower insulin
action in MZ compared with DZ twins [22]. In a study
comprising 50 twins and 20 singletons, Jeffries and col-
leagues [23] demonstrated that twins are at higher risk of
developing metabolic abnormalities, whereas Bo and col-
leagues [24] showed that in twins, within-pair differences in
BW were associated with an unfavourable response to
OGTT. Conversely, BW was neither a predictor of adult
glucose tolerance in 58 MZ twins from the Birmingham
Table 4 Comparison of indices of glucose metabolism calculated on the basis of a 2 h OGTT in BW-discordant MZ twins
Measure MZ pairs with complete data
on OGTT (n0148 pairs)
MZ pairs with BW difference
of >0.5 kg (n044)
Pairs with double verification
of BW discordance
(n0129)
Pairs without metabolic
disease (n0118)
Difference,
mean±SD or median
(interquartile range)
p Difference,
mean±SD or median
(interquartile range)
p Difference,
mean±SD or median
(interquartile range)
p Difference,
mean±SD or median
(interquartile range)
p
HOMA-βa 0.0 (−16.1, 17.6) >0.1 −0.1 (−10.9, 17.0) >0.1 0.0 (−18.6, 18.9) >0.1 0.0 (−17.0, 17.9) >0.1
HOMA-IRa −0.02 (−0.5, 0.6) >0.1 −0.06 (−4.3, 7.3) >0.1 0.0 (−0.4, 0.5) >0.1 −0.01 (−0.4, 0.5) >0.1
BIGTT- SI0-30-120 −0.2±3.5 >0.1 −0.2±3.4 >0.1 −0.2±3.6 >0.1 −0.3±3.4 >0.1
BIGTT-AIR0-30-120 50.6±268.8 0.03 9.7±233.7 >0.1 44.8±267.2 0.08 64.5±271.0 0.01
AUCglucose (mmol/l×h) 6.4±168.0 >0.1 21.0±164.0 >0.1 11.8±173.0 >0.1 15.8±164.9 >0.1
AUCGLP1 (pmol/l×h) −17.0±832.4 >0.1 61.4±666.9 >0.1 −8.9±820.6 >0.1 −9.7±747.6 >0.1
AUCGIP (pmol/l×h) −46.5±1941.1 >0.1 −104.0±2145.2 >0.1 −82.0±1997.5 >0.1 −15.4±1707.6 >0.1
Twins with the higher BW were compared with the twins with the lower BW using Student’s t test
a Statistical test after log-transformation
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Twin Study [25] nor associated with insulin resistance in a
study comprising more than 1,000 female twins [26]. More-
over, Johansson and colleagues [10] reported that low BW
and type 2 diabetes were associated in a population-based
study comprising more than 11,000 Swedish twins. Interest-
ingly, the same investigators showed that among twins
discordant for type 2 diabetes, low BW was associated with
type 2 diabetes in DZ but not MZ twins, indicating that
genetic factors contribute significantly to the observed as-
sociation between BW and risk of type 2 diabetes [10]. In
addition, although the BW of twins is generally lower than
that of singletons, the prevalence of type 2 diabetes in twins
is analogous to that observed in the background population
[3, 10]. These previous studies have provided diverse results
on the association between BW and type 2 diabetes, which
may be explained by differences in study design and, in
particular, varying power.
Owing to the importance of genetics and environment on
both fetal growth and adult health, it is challenging to
investigate the interaction between early life factors (i.e.
BW) and adverse health consequences in adulthood in
singletons. However, comparing MZ twins discordant for
BW makes it possible to control for a number of important
confounders including most notably genetics, maternal age,
parity, gestational age, and, to some extent, postnatal envi-
ronment. Although this study was conducted among highly
selected MZ twins and one may dispute whether our obser-
vations are relevant to other twins and in particular single-
tons, the discordant twin model provides a superior
opportunity to study the independent effects of BW on adult
health.
Certain twin-specific conditions may impair the growth
of one twin while favouring the growth of the other (e.g.
placental anastomosis) causing the twins to become BW
discordant. While zygosity appears not to be a major pre-
dictor of adverse perinatal outcomes, monochorionicity is
associated with unfavourable health-related consequences in
perinatal life [27–29]. Information on chorionicity was un-
available in our study population, but we were able to assess
glucose metabolism in both the largest and smallest twins.
Even though twin pairs with substantial BW discordance
were more likely to be monochorionic, these analyses did
not indicate any difference in adult glucose metabolism.
Nevertheless, the long-term consequences of chorionicity
are not clear, and Loos and colleagues reported that the
chorion type of MZ twins had no impact on adult anthro-
pometrics including fat distribution [30]. Furthermore, even
dramatic differences in weight in MZ twins at birth tend to
disappear during childhood [31], suggesting that the diver-
gence is not causing extensive and permanent physical
changes that render comparison with other individuals un-
reasonable. In addition, the mortality rate in MZ twins after
the age of 6 years is similar to that in DZ twins and
singletons[32], implying that zygosity and chorionicity are
unlikely to be of major importance in the assessment of
effects of BW on adult health.
Although factors in early postnatal life may have been
similar, non-shared postnatal experiences, unaccounted for
in the present study, may have influenced important aspects
of health in adulthood, including glucose metabolism.
Nevertheless, if BW had a substantial effect on glucose
metabolism that was independent of genetic and rearing
environment, differences in the prevalence of diabetes, in-
appropriate response to glucose loading or levels of fasting
p-glucose would have been expected in the present study.
Although we found no differences in glucose metabolism
between BW-discordant MZ twins, we cannot reject the
possibility that low BW influences health in later life. It
has been suggested that genetic variations may change the
levels of insulin in utero and increase the risk of diabetes in
later life [33]. Studies have provided evidence of a genetic
explanation for the association between BW and risk of
diabetes, and genetic mutations known to cause monogenic
forms of diabetes may result in reduced BW [33, 34].
Furthermore, fetal inheritance of type 2 diabetes suscepti-
bility variants has been associated with lower BW [35].
Therefore, genetics seem to contribute significantly to the
association between BW and health in later life.
The present study has weaknesses. First, we assessed the
glucose metabolism using the OGTT, which is associated with
substantial intra- and intervariability [36, 37], althoughOGTT,
HOMA, and BIGTT have been shown to provide reliable
estimates of insulin sensitivity and beta cell function [15].
Second, the incretin response may have been different if the
study participants had received a meal test rather than an
OGTT. Third, recruiting extremely BW-discordant MZ twins
could contribute bias towards an association between low BW
and health due to higher frequency of underlying disease
among the low-BW participants. Fourth, measurement error
in the exposure (i.e. BW) is a critical factor in within-twin-pair
comparisons. Reassuringly, virtually all participants reporting
whether they were born at the higher or the lower BWwere in
agreement (>99%). Fifth, information about BW was not
available in all MZ twin pairs in the Danish Twin Registry,
which may explain the low level of BW discordance observed
in some of the participants. This is, however, unlikely to
interfere with the results of the study since no indication of
an independent effect of BW on glucose metabolism was
identified in the subgroup consisting of twin pairs with
a large difference in BW.
In conclusion, our results do not support any major
impact of intrauterine factors, as mirrored by BW, on
glucose homeostasis in adulthood once genetic and environ-
mental factors are controlled for. These observations are in
concord with previous large register-based studies showing
similar prevalence of diabetes in twins and singletons.
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